This contract is an award to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine and radiopharmaceuticals. The contract, valued at $437,828.29, was awarded by the U.S. Department of Veterans Affairs (VA) for the delivery of radioactive isotopes. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Triad Isotopes has previously provided radiopharmaceuticals to various VA Integrated Service Networks (VISNs), including VISN 15 and VISN...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The contract, valued at $557,104.95, is for the delivery of radioactive isotopes to the VA. This appears to be a delivery order under a larger VA contract vehicle, as Triad Isotopes has received additional awards from the VA's Veterans Integrated Service Networks (VISNs) to provide radiopharmaceuticals to veteran's hospitals,...
This is a federal contract award to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine, for the provision of various radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract award, valued at $562,331.07, is a delivery order under a larger contract vehicle. The contract is for the delivery of radiopharmaceuticals to the VA's Veterans Integrated Service Network 1 (VISN 1) and does not have a set-aside designation. Triad Isotopes has...
This federal contract award was made by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The $128,160.16 firm fixed-price delivery order is for the provision of radiopharmaceuticals to support the VA's healthcare services for veterans. The contract has no set-aside designation. Triad Isotopes has previously received other VA contract awards to...
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The contract is for the delivery of radiopharmaceuticals, with a ceiling value of $252,814.35. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Triad Isotopes has provided similar radiopharmaceuticals to other VA networks, including VISN 15 and VISN 1, through previous delivery orders. This award is...
This federal contract award, valued at $161,481.90, was issued by the Veterans Integrated Service Network 8 (VISN 8), which is part of the U.S. Department of Veterans Affairs (VA), to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine. The contract is for the delivery of radiopharmaceuticals, which are radioactive agents used in nuclear medicine procedures. The contract type is Delivery Order, with a Firm Fixed Price pricing structure, and it has an ultimate...
This federal contract award to Triad Isotopes, Inc. is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract, valued at $120,700.75, is a delivery order under a larger federal contract vehicle. Triad Isotopes is a pharmaceutical company that specializes in nuclear medicine and has previously provided radiopharmaceuticals to various VA healthcare networks. The contract has a performance period through September 30, 2016 and is a firm fixed-price...
This federal contract award is for the delivery of radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through the Veterans Integrated Service Network (VISN) 21. The prime contractor is Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine. The contract has a potential value of $130,474.98 and is a Firm Fixed Price Delivery Order with no set-aside designation. Triad Isotopes has provided similar radiopharmaceuticals...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine and radiopharmaceuticals. The contract is for the delivery of radioactive isotopes, with a firm fixed price and a potential value of $450,630.34. The contract was awarded on October 1, 2017, with a completion date of January 25, 2019. The contract does not have a set-aside designation. Triad Isotopes has...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 1 (VISN 1), a civilian agency under the Department of Veterans Affairs, to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The contract is for the delivery of radiopharmaceuticals to support the VA's Biomedical Health Services (BHS) program, with a ceiling value of $490,432.36 and a period of performance from October 1, 2016 to November 1, 2018. The contract does...